SponsorsOne Enters the $4.9 Billion Pet Nutraceuticals Marketplace
(firmenpresse) - SponsorsOne Enters the $4.9 Billion Pet Nutraceuticals Marketplace
Waterloo, Ontario, November 14, 2018: SponsorsOne Inc., (CSE: SPO) (Frankfurt: 5SO) the company that makes small brands BIG by building large, engaged and authentic communities that buy and support the Brands they love, is pleased to announce it has entered into a Brand Development Agreement with GrowthCell Global Corporation. Under the agreement, SponsorsOne will develop a full branding and marketing launch in North America utilizing SponsorsOne's unique and patented storytelling and micro-influencer platform - SponsorCoin.
Our patented PetCell formula is the missing ingredients that their canine ancestors depended upon to thrive in the wild," said Pam Lehr, Chief Business Development Officer. " Scientific research and real life experiences have proven that PetCell, which contains Natural Growth Factors, has been effective in addressing problems associated with everyday pet health.
"The pet nutraceuticals market is projected to be $8.25 billion in 20221," added Myles Bartholomew, CEO of SponsorsOne. "Our technology will introduce a new form of digital marketing to this sector helping GrowthCell Global reach their market direct through social media."
PetCell is the first natural formula that is scientifically proven to have anti-aging effects on cellular/tissue levels by the way of exert cyto-stimulating, cyto-protective and anti-oxidative properties. These break-through anti-aging formulas contain natural occurring growth factors & peptides responsible for reprogramming adult stem cells and amino acids in the pet. Scientific Research has clearly indicated that natural agents of PetCell formula helps with the production of Cortisol and Insulin in the physiologically optimal amount, naturally alleviating several common dog diseases and symptoms like Diabetes Mellitus, Diabetes Insipidus, Cushings Disease, Hypothyroidism, Idiopathic Colitis, After Surgery - improved appetite and mood, Locomotor Disorder, Skin Issues, Mental Disorders.
SponsorsOne will launch PetCell in December 2018 and will be available for purchase online direct to the per owners.
About GrowthCell Global Corporation:
GrowthCells formula with a patented cellular communication technology that will help your pets overall ailments and health infuses nutraceuticals with a patented oligopeptide known as GrowthCell . It is also know to increase the bioavailability of CBD. These break-through anti-aging formulas contain natural occurring growth factors & peptides responsible for reprogramming stem cells and amino acids in the pet. PetCell will be sold in North America.
About SponsorsOne:
SponsorsOne is the leader in the next evolution of digital marketing through storytelling and digital-commerce with the SponsorsCloud platform and its highly scalable digital - smart contract based digital-currency called SponsorCoin. Combined, this allows Brands to build and manage exclusive and highly engaged communities of micro-influencers within the social realm. The SponsorsCloud platform provides for data-driven marketing campaigns that will change the way brands connect to their customers and to compensate the consumer for authentic engagement using the SponsorCoin digital currency. SponsorsCloud and SponsorCoin is a tool for brands to inspire real movements around their products and services in which their most valuable customers become their best salespeople, producing far higher ROI than current social media advertising methods.
ON BEHALF OF THE BOARD
Gary Bartholomew, Executive Chairman
To learn more please visit http://sponsorsone.com
The Canadian Securities Exchange (CSE) has neither approved nor disapproved the contents of this Press Release.
Forward-Looking Statements
This news release contains forward-looking statements and information that are based on the beliefs of management and reflect the Companys current expectations. When used in this news release, the words estimate, project, belief, anticipate, intend, expect, plan, predict, may or should and the negative of these words or such variations thereon or comparable terminology, are intended to identify forward-looking statements and information. Such statements and information reflect the current view of the Company with respect to risks and uncertainties that may cause actual results to differ materially from those contemplated in those forward-looking statements and information.
By their nature, forward-looking statements involve known and unknown risks, uncertainties and other factors which may cause actual results, performance or achievements, or other future events, to be materially different from any future results, performance or achievements expressed or implied by such forward-looking statements. Such factors include, among others, the following risks: risks associated with marketing and sale of securities; the need for additional financing requirements and access to capital, reliance on key personnel; the potential for conflicts of interest among certain officers or directors with certain other projects; the volatility of the volume and price of the Common Shares, the failure of the business strategy, the integrity of the Companys patents and proprietary intellectual property and competition. The Company cautions that the foregoing list of risk factors is not exhaustive and is subject to change and there can be no assurance that such assumptions will reflect the actual outcome of such items or factors. When relying on the Companys forward-looking statements and information to make decisions, investors and others should carefully consider the foregoing factors and other uncertainties and potential events, including the risk factors set out in the Companys Listing Statement. The Company has assumed a certain progression, which may not be realized. It has also assumed that the material factors referred to above will not cause such forward-looking statements and information to differ materially from actual results or events.
THE FORWARD-LOOKING INFORMATION CONTAINED IN THIS NEWS RELEASE REPRESENTS THE EXPECTATIONS OF THE COMPANY AS OF THE DATE OF THIS NEWS RELEASE AND, ACCORDINGLY, IS SUBJECT TO CHANGE AFTER SUCH DATE. READERS SHOULD NOT PLACE UNDUE IMPORTANCE ON FORWARD-LOOKING INFORMATION AND SHOULD NOT RELY UPON THIS INFORMATION AS OF ANY OTHER DATE. WHILE THE COMPANY MAY ELECT TO, IT DOES NOT UNDERTAKE TO UPDATE THIS INFORMATION AT ANY PARTICULAR TIME EXCEPT AS REQUIRED IN ACCORDANCE WITH APPLICABLE SECURITIES LEGISLATION.
Leseranfragen:
" alt="Golden Ridge Completes Option Agreement with Barrick; Earns 100% Interest in The Hank Project">
" alt="International Cannabis Reports No Material Change">
Datum: 14.11.2018 - 09:07 Uhr
Sprache: Deutsch
News-ID 583946
Anzahl Zeichen: 6800
contact information:
Town:
Wien
Kategorie:
Business News
Diese Pressemitteilung wurde bisher 141 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"SponsorsOne Enters the $4.9 Billion Pet Nutraceuticals Marketplace
"
steht unter der journalistisch-redaktionellen Verantwortung von
SponsorsOne Inc. (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
